Streetbeat News

ELLXF

Elixinol Wellness Limited

http://elixinolglobal.com/

CEO

Oliver Horn

Industry

All Other Miscellaneous Chemical Product and Preparation Manufacturing

Open

0.00

Mkt cap

4.5M

Volume

12K

High

0.00

P/E Ratio

-0.29

52-wk high

0.02

Low

0.00

Div yield

N/A

52-wk low

0.00

The article lists the cannabis stocks that experienced significant gains and losses on January 31, 2024. Notable gainers include Rhinomed, GrowLife, and Elixinol Wellness with increases of 200%, 100%, and 69.3% respectively. On the losing side, MedMen Enterprises and EVIO both plummeted by 99%. The article also mentions several other cannabis-related companies with varying degrees of price changes.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 9:30 pm

The article reports on the significant price movements of various cannabis-related stocks on January 30, 2024. Notable gainers include MedMen Enterprises, EVIO, Corbus Pharmaceuticals, and others, with MedMen and EVIO both closing up 9900.00% at $0.0001. On the losing side, Rhinomed led the declines with a 73.54% drop. The article lists both gainers and losers with their respective percentage changes and closing prices.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 24, 2024. Notable gainers included Global Hemp Group, Target Group, and Item 9 Labs, with increases of 68.40%, 47.06%, and 14.29% respectively. Trulieve Cannabis and MJ Holdings also saw gains over 11%. Corbus Pharmaceuticals and Neptune Wellness Solutions were among the NASDAQ-listed gainers. Conversely, MedMen Enterprises and EVIO suffered dramatic losses, closing down 99.99% and 98.00%. Other notable losers included Khiron Life Sciences and Cara Therapeutics. The article was generated by Benzinga's automated content engine and reviewed by an editor.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 9:30 pm

On January 23, 2024, several cannabis stocks experienced significant price movements. MedMen Enterprises led the gainers with a 999900.00% increase, closing at $0.01, while Pharmadrug led the losers with a 25.23% decrease, closing at $0.03. Notable gainers included Cann Gr, Khiron Life Sciences, and Canopy Growth, with increases of 125.92%, 59.09%, and 5.22% respectively. Among the losers, Greenlane Holdings and OrganiGram Holdings saw declines of 5.20% and 3.96%. The article was generated by Benzinga's automated content engine.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 9:30 pm

On January 22, 2024, several cannabis-related stocks experienced significant price movements. Notable gainers included Cansortium, Global Hemp Group, and Blueberries Medical, with increases of 27.27%, 25.00%, and 18.18% respectively. Urban-gro, OrganiGram Holdings, and Psychemedics also saw gains on NASDAQ. Conversely, AusCann Group Holdings, EVIO, and Maple Leaf Green World were among the biggest losers, with AusCann's shares plummeting by 59.42%. Corbus Pharmaceuticals and Eastside Distilling also experienced declines on NASDAQ.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 19, 2024. EVIO led the gainers with a 9900.00% increase, while Rocky Mountain High topped the losers with a 21.62% decline. Notable gainers included Genetic Technologies, OrganiGram Holdings, and Cara Therapeutics, with increases of 42.16%, 10.72%, and 4.80% respectively. Among the losers, Corbus Pharmaceuticals and Greenlane Holdings saw declines of 4.91% and 3.32%.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 9:30 pm

The cannabis sector experienced bearish sentiment on January 18, 2024, with a mix of gainers and losers. Notable gainers included Genetic Technologies (GENE) and Urban-gro (UGRO), while significant losers were Aurora Cannabis (ACB), GrowGeneration (GRWG), OrganiGram Holdings (OGI), Tilray Brands (TLRY), Neptune Wellness Solutions (NEPT), Canopy Growth (CGC), Corbus Pharmaceuticals (CRBP), and Village Farms International (VFF).

Portfolio Pulse from Benzinga Insights

January 18, 2024 | 9:30 pm

On January 17, 2024, several cannabis stocks experienced significant price movements. AusCann Group Holdings led the gainers with a 187.50% increase, while MedMen Enterprises and GreenGro Technologies were the biggest losers, both dropping by over 99%. Other notable gainers include Khiron Life Sciences and Maple Leaf Green World, with increases of 54.29% and 32.45%, respectively. Among the losers, 22nd Century Group and OrganiGram Holdings saw declines of 14.72% and 7.89%. The movements reflect the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 10, 2024. Choom Holdings, EVIO, Global Hemp Group, Global Compliance, Cannabix Technologies, Body and Mind, Pharmadrug, Neptune Wellness Solutions, and Trees saw gains, with Choom Holdings leading with a 9900% increase. Conversely, Acacia Diversified Holdings led the losers with a 99% decline, followed by significant losses in Cann Gr, Khiron Life Sciences, CordovaCann, Elixinol Wellness, 1933 Industries, Item 9 Labs, Affinor Growers, 4Front Ventures, C21 Investments, Heritage Cannabis Holding, Cresco Labs, Leafbuyer Techs, Trulieve Cannabis, Eastside Distilling, Curaleaf Holdings, Cara Therapeutics, Indiva, Auxly Cannabis Group, RIV Capital, Tilray Brands, Greenlane Holdings, iAnthus Capital Holdings, Psychemedics, SNDL, and SOL Global Investments.

Portfolio Pulse from Benzinga Insights

January 10, 2024 | 9:30 pm

The marijuana stock market saw significant movements on January 9, 2024, with a mix of gainers and losers. Notable gainers included AusCann Group Holdings, Rocky Mountain High, and Item 9 Labs with substantial percentage increases in their share prices. On the other hand, Australis Capital and Choom Holdings experienced dramatic declines, with Australis Capital shares closing down 100%. Other notable losers included Tilray Brands, Canopy Growth, and SNDL with significant percentage decreases. This market activity reflects the volatile nature of the marijuana industry stocks.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.